Fingerprint
Dive into the research topics of 'Atomoxetine for the treatment of executive dysfunction in Parkinson's disease: A pilot open-label study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Atomoxetine for the treatment of executive dysfunction in Parkinson's disease: A pilot open-label study
Laura Marsh, Kevin Biglan, Melissa Gerstenhaber, James R. Williams
Research output: Contribution to journal › Article › peer-review
92
Scopus
citations